Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds

Table 3 Propensity score analysis

	Patient level				Lesion level
	Unadjusted		Average treatment effect-adjusted		Unadjusted		Average treatment effect -adjusted
	p	HR 95% CI	p	HR 95% CI	p	HR 95% CI	p	HR 95% CI
DoCE	0.026	1.74 [1.07–2.83]	0.0026	1.59 [1.18–2.16]	0.045	1.65 [1.01–2.68]	0.003	1.58 [1.17–2.13]
ScT	0.6	0.75 [0.26–2.18]	0.43	0.79 [0.44–1.42]	0.52	0.7 [0.24–2.05]	0.2	0.68 [0.37–1.23]
ScR	0.0067	2.52 [1.29–4.91]	0.00038	2.2 [1.42–3.41]	0.0051	2.37 [1.3–4.35]	0.00077	1.97 [1.33–2.92]

ISSN: 1471-2261